An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

PAR-22-031 - Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): AI/ML in Pre-Clinical Drug Development for Psychiatric Disorders	NOT-MH-25-050	NIMH	Dec 20, 2024	Sep 9, 2025	R21, R01
Notice of Special Interest (NOSI): Discovery and Development of Natural Products to Treat Substance Use Disorders (SUDs)	NOT-DA-25-032	NIDA, NCCIH	Nov 25, 2024	Sep 9, 2025	R01, UG3/UH3, U01, R21

For technical issues E-mail OER Webmaster

Redirect Notice

PAR-22-031 - Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Stay Connected

Government Sites

Web Policies and Notices

Site Map